ArticleInternational journal of cardiology. Heart & vasculature2023

Efficacy and safety of the endothelin-1 receptor antagonist macitentan in epicardial and microvascular vasospasm; a proof-of-concept study.

Rutger G T Feenstra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.